|
Market Closed -
Nasdaq
00:00:00 26/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.6395 USD | -2.49% |
|
-2.01% | -59.53% |
| 09-21 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to S&P Global BMI Index | CI |
| 08-28 | Outlook Therapeutics, Inc. Announces CFO Changes, Effective September 1, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 156M | - | - | - | ||
| 47.97B | |||||
| 44.5B | |||||
| 43.93B | - | - | - | - | - |
| 41.03B | |||||
| 29.85B |
Select your edition
All financial news and data tailored to specific country editions
